United States
US 12,697,404 B2
PSMA-targeting conjugate and uses thereof
US 12,697,404 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: ORANO MED. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- ORANO MED
- Inventors
- Amal Saidi; Amy Wong; Julien Torgue; Tania Stallons
- Publication date
- 2026-08-04
- Filing date
- 2023-07-18
- Document type
- B2 Granted patent
- Also written as
- US 12,697,404 B2 · US12697404 · 12697404
Abstract
A PSMA-targeting conjugate or a pharmaceutically acceptable salt which may be used either for preparing a radiopharmaceutical or, once labeled with a radionuclide, as a radiopharmaceutical. The conjugate is of formula (I): A1-L1-Ch-L2-A2 (I)wherein: Ch is a chelator, L1 and L2, identical or different, are a linker whereas A1 and A2, identical or different, are a urea-based PSMA ligand.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free